drugset / Trial / NCT06824844

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

NCT06824844

Phase 4 Completed 60 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this study is to observe the effects of 0.05% cyclosporine eye drops combined with artificial tears on patients with diabetes-associated dry eye, and to monitor changes in ocular surface characteristics and inflammatory cytokines in tears before and after treatment.

Timeline

Start
2021-12-02
Primary completion
2024-03-04
Completion
2024-06-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 0.05 % Topical

Indications